Updated: March 23, 2021 Premas Biotech and Oramed announce oral COVID-19 vaccine candidate that produces antibodies after a single dose Must Read Nationalindonesianupdates.com_admin - January 31, 2026Jakarta govt prioritizes residents’ safety at Rorotan RDF Plant Nationalindonesianupdates.com_admin - January 31, 2026Death toll rises as SAR finds more landslide victims in Cisarua Nationalindonesianupdates.com_admin - January 31, 2026Prabowo meets opposition figures to address state budget leakages Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. … Previous articleNeed GeNose in factories to revive economic activity: ministerNext articleState spending increased 1.2 percent as of February 2021: Mulyani Latest News National - January 31, 2026Jakarta govt prioritizes residents’ safety at Rorotan RDF PlantThe Jakarta Provincial Government ensured the continuation of the Rorotan Refuse-Derived Fuel (RDF) Plant's ... National Death toll rises as SAR finds more landslide victims in Cisarua - January 31, 2026 National Prabowo meets opposition figures to address state budget leakages - January 31, 2026 National Indonesia tightens cruise ship oversight to protect coral reefs - January 31, 2026 National Indonesia warns of Nipah virus risk from migrating birds, bats - January 31, 2026 More Articles Like This President Jokowi calls for a shift in defense policy BREAKING NEWS - October 5, 2021 Black & Veatch management consulting chosen to help drive SCG International’s electric vehicle transition in Thailand BREAKING NEWS - October 5, 2021 Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system BREAKING NEWS - October 5, 2021 PPKM outside Java-Bali extended till Oct 18 BREAKING NEWS - October 4, 2021
Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. …